Alkem Laboratories Ltd
BSE:539523
Alkem Laboratories Ltd
BSE:539523
Price:
5 145.6
INR
-2.13%
Market Closed
Market Cap:
₹615.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Alkem Laboratories Ltd
BSE:539523
|
IN |
|
Porr AG
LSE:0J04
|
AT |
|
Genting Hong Kong Ltd
HKEX:678
|
HK |
|
E
|
Eco Bright Future Inc
OTC:EBFI
|
US |
|
C
|
CFM Holdings Ltd
SGX:5EB
|
SG |
|
Industrial Bank of Korea
KRX:024110
|
KR |
|
Exela Technologies Inc
NASDAQ:XELA
|
US |
|
S
|
Scan Inter PCL
SET:SCN
|
TH |
|
G
|
Global Hydrogen SA
WSE:GHY
|
PL |
|
Safran SA
PAR:SAF
|
FR |
Relative Value
The Relative Value of one
ALKEM
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 5 145.6 INR,
Alkem Laboratories Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALKEM Relative Value
HIDDEN
Multiples Across Competitors
ALKEM Competitors Multiples
Alkem Laboratories Ltd Competitors
Alkem Laboratories Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Alkem Laboratories Ltd
BSE:539523
|
615.1B INR | 4.4 | 26.6 | 20.5 | 23.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.1 | 41.3 | 27.9 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.8 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP | 4.9 | 28 | 15.6 | 22 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 5.1 | 20.7 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
